{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:34:42Z","timestamp":1790400882511,"version":"4.1.0"},"reference-count":34,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>Breast cancer is the most common cancer in women, but its incidence can only be partially explained through established risk factors. Our aim was to use metabolomics to identify novel risk factors for breast cancer and to validate recently reported metabolite-breast cancer findings. We measured levels of 1275 metabolites in prediagnostic serum in a nested case-control study of 782 postmenopausal breast cancer cases and 782 matched controls. Metabolomics analysis was performed by Metabolon Inc using ultra-performance liquid chromatography and a Q-Exactive high resolution\/accurate mass spectrometer. Controls were matched by birth date, date of blood draw, and race\/ethnicity. Odds ratios (ORs) and 95% confidence intervals (CIs) of breast cancer at the 90th versus 10th percentile (modeled on a continuous basis) of metabolite levels were estimated using conditional logistic regression, with adjustment for age. Twenty-four metabolites were significantly associated with breast cancer risk at a false discovery rate &lt;0.20. For the nine metabolites positively associated with risk, the ORs ranged from 1.75 (95% CI: 1.29\u20132.36) to 1.45 (95% CI: 1.13\u20131.85), and for the 15 metabolites inversely associated with risk, ORs ranged from 0.59 (95% CI: 0.43\u20130.79) to 0.69 (95% CI: 0.55\u20130.87). These metabolites largely comprised carnitines, glycerolipids, and sex steroid metabolites. Associations for three sex steroid metabolites validated findings from recent studies and the remainder were novel. These findings contribute to growing data on metabolite-breast cancer associations by confirming prior findings and identifying novel leads for future validation efforts.<\/jats:p>","DOI":"10.3390\/metabo11020095","type":"journal-article","created":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T16:12:10Z","timestamp":1613146330000},"page":"95","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["A Metabolomics Analysis of Postmenopausal Breast Cancer Risk in the Cancer Prevention Study II"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8169-1661","authenticated-orcid":false,"given":"Steven C.","family":"Moore","sequence":"first","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20895, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn M.","family":"Mazzilli","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20895, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua N.","family":"Sampson","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20895, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Matthews","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20895, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Carter","sequence":"additional","affiliation":[{"name":"Department of Population Science, American Cancer Society, Atlanta, GA 30303, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary C.","family":"Playdon","sequence":"additional","affiliation":[{"name":"Cancer Control and Population Sciences, Huntsman Cancer Institute, Salt Lake City, UT 84112, USA"},{"name":"Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, UT 84112, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1241-6252","authenticated-orcid":false,"given":"Ying","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Population Science, American Cancer Society, Atlanta, GA 30303, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria L.","family":"Stevens","sequence":"additional","affiliation":[{"name":"Department of Population Science, American Cancer Society, Atlanta, GA 30303, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/jnci\/djn330","article-title":"Increasing breast cancer incidence in China: The numbers add up","volume":"100","author":"Ziegler","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/jnci\/djt157","article-title":"Cancer incidence trends among Asian American populations in the United States, 1990\u20132008","volume":"105","author":"Gomez","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Collaborative Group on Hormonal Factors in Breast C (2002). Breast cancer and breastfeeding: Collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50,302 women with breast cancer and 96,973 women without the disease. Lancet, 360, 187\u2013195.","DOI":"10.1016\/S0140-6736(02)09454-0"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3322\/caac.21440","article-title":"Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States","volume":"68","author":"Islami","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1249\/MSS.0000000000002117","article-title":"American College of Sports Medicine Roundtable Report on Physical Activity, Sedentary Behavior, and Cancer Prevention and Control","volume":"51","author":"Patel","year":"2019","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"Body Fatness and Cancer\u2014Viewpoint of the IARC Working Group","volume":"375","author":"Scoccianti","year":"2016","journal-title":"New Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Thompson CB. Understanding the Warburg effect: The metabolic requirements of cell proliferation","volume":"324","author":"Cantley","year":"2009","journal-title":"Science"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/ije\/dyx271","article-title":"NMR metabolomic signatures reveal predictive plasma metabolites associated with long-term risk of developing breast cancer","volume":"47","author":"Bala","year":"2018","journal-title":"Int. J. Epidemiol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"K\u00fchn, T., Floegel, A., Sookthai, D., Johnson, T., Rolle-Kampczyk, U., Otto, W., Von Bergen, M., Boeing, H., and Kaaks, R. (2016). Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study. BMC Med., 14.","DOI":"10.1186\/s12916-016-0552-3"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"16534","DOI":"10.1038\/s41598-020-73499-x","article-title":"Circulating branched-chain amino acids and long-term risk of obesity-related cancers in women","volume":"10","author":"Tobias","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3945\/ajcn.116.150912","article-title":"Nutritional metabolomics and breast cancer risk in a prospective study","volume":"106","author":"Playdon","year":"2017","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_14","first-page":"588","article-title":"A Metabolomics Analysis of Body Mass Index and Postmenopausal Breast Cancer Risk","volume":"110","author":"Moore","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"His, M., Viallon, V., Dossus, L., Gicquiau, A., Achaintre, D., Scalbert, A., Ferrari, P., Romieu, I., Onland-Moret, N.C., and Weiderpass, E. (2019). Prospective analysis of circulating metabolites and breast cancer in EPIC. BMC Med., 17.","DOI":"10.1186\/s12916-019-1408-4"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/jnci\/94.8.606","article-title":"Breast Cancer Collaborative G. Endogenous sex hormones and breast cancer in postmenopausal women: Reanalysis of nine prospective studies","volume":"94","author":"Key","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1677\/erc.1.01038","article-title":"Postmenopausal serum androgens, oestrogens and breast cancer risk: The European prospective investigation into cancer and nutrition","volume":"12","author":"Kaaks","year":"2005","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s10549-012-2391-z","article-title":"Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up","volume":"137","author":"Zhang","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_19","first-page":"161","article-title":"Minireview: 16alpha-hydroxylated metabolites of dehydroepiandrosterone and their biological significance","volume":"34","author":"Hampl","year":"2000","journal-title":"Endocr. Regul."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.steroids.2015.02.015","article-title":"Epidemiologic studies of estrogen metabolism and breast cancer","volume":"99","author":"Ziegler","year":"2015","journal-title":"Steroids"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1158\/0008-5472.CAN-16-1717","article-title":"Association of Estrogen Metabolism with Breast Cancer Risk in Different Cohorts of Postmenopausal Women","volume":"77","author":"Sampson","year":"2017","journal-title":"Cancer Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jsbmb.2004.04.009","article-title":"Partial agonist\/antagonist properties of androstenedione and 4-androsten-3\u03b2,17\u03b2-diol","volume":"91","author":"Chen","year":"2004","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1177\/039463200501800425","article-title":"Glutaric aciduria type II: A case report","volume":"18","author":"Domizio","year":"2005","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1096\/fj.12-216689","article-title":"Carnitine palmitoyltransferase 2 and carnitine\/acylcarnitine translocase are involved in the mitochondrial synthesis and export of acylcarnitines","volume":"27","author":"Violante","year":"2013","journal-title":"FASEB J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"9880","DOI":"10.3748\/wjg.v22.i45.9880","article-title":"Hepatic steatosis and fibrosis: Non-invasive assessment","volume":"22","author":"Karanjia","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nrc3162","article-title":"Choline metabolism in malignant transformation","volume":"11","author":"Glunde","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Moore, S.C. (2020). Metabolomics and breast cancer: Scaling up for robust results. BMC Med., 18.","DOI":"10.1186\/s12916-019-1484-5"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1158\/1055-9965.EPI-12-1109","article-title":"Metabolomics in epidemiology: Sources of variability in metabolite measurements and implications","volume":"22","author":"Sampson","year":"2013","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/aje\/kwz028","article-title":"The Consortium of Metabolomics Studies (COMETS): Metabolomics in 47 Prospective Cohort Studies","volume":"188","author":"Yu","year":"2019","journal-title":"Am. J. Epidemiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/cncr.10197","article-title":"The American Cancer Society Cancer Prevention Study II Nutrition Cohort: Rationale, study design, and baseline characteristics","volume":"94","author":"Calle","year":"2002","journal-title":"Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1021\/ac901536h","article-title":"Integrated, nontargeted ultrahigh performance liquid chromatography\/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems","volume":"81","author":"Evans","year":"2009","journal-title":"Anal. Chem."},{"key":"ref_32","first-page":"132","article-title":"High Resolution Mass Spectrometry Improves Data Quantity and Quality as Compared to Unit Mass Resolution Mass Spectrometry in High-Throughput Profiling Metabolomics","volume":"4","author":"Evans","year":"2014","journal-title":"Metabolomics"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/bib\/bbu033","article-title":"Rediscovery rate estimation for assessing the validation of significant findings in high-throughput studies","volume":"16","author":"Ganna","year":"2014","journal-title":"Brief Bioinform."}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/11\/2\/95\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:22:27Z","timestamp":1760160147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/11\/2\/95"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,10]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["metabo11020095"],"URL":"https:\/\/doi.org\/10.3390\/metabo11020095","relation":{},"ISSN":["2218-1989"],"issn-type":[{"value":"2218-1989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,10]]}}}